250 The second RCT reported in a much larger sample (131 BCG patients, 134 placebo patients) no differences in response rate between treatment arms (21% in the BCG group compared to 12% in the placebo groups) at seven months with 95% of patients in each group reporting at least one AE
To ensure market exclusivity, Novo Nordisk and Eli Lilly have secured patents for these drugs worldwide
Statin-induced apoptosis and skeletal myopathy
Lee B, Bauer H, Melchers J, Ruppert T, Rattray L, et al
Muscle is a metabolically active tissue that helps you move, burn calories, and maintain strength
Both Novo Nordisk ($10 billion) and Eli Lilly ($27 billion) have already committed to major US manufacturing investments, positioning them for potential three-year tariff exemptions tied to onshoring timelines